Skip to content
10-Q

Quarterly Report

ALSERES PHARMACEUTICALS INC /DE

0001193125-14-309279

← back to feed
Filed
Aug 14, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Jul 31, 2014 30.64M sh
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$657.51K
Operating Cash Flow Q2 2014 · Jun 30, 2013 −$1M
Short Term Investments Q2 2014 · Jun 30, 2014 $140.51K
Short Term Investments Q2 2014 · Dec 31, 2013 $196.65K
Cash And Equivalents Q2 2014 · Jun 30, 2014 $46.44K
Cash And Equivalents Q2 2014 · Dec 31, 2013 $113.96K
Cash And Equivalents Q2 2014 · Jun 30, 2013 $27.98K
Cash And Equivalents Q2 2014 · Dec 31, 2012 $16.53K
Stockholders Equity Q2 2014 · Jun 30, 2014 −$11.38M
Stockholders Equity Q2 2014 · Dec 31, 2013 −$10.66M
Current Liabilities Q2 2014 · Jun 30, 2014 $1.81M
Current Liabilities Q2 2014 · Dec 31, 2013 $1.65M
Total Liabilities Q2 2014 · Jun 30, 2014 $11.26M
Total Liabilities Q2 2014 · Dec 31, 2013 $10.65M
Current Assets Q2 2014 · Jun 30, 2014 $220.04K
Current Assets Q2 2014 · Dec 31, 2013 $324.64K
Total Assets Q2 2014 · Jun 30, 2014 $279.03K
Total Assets Q2 2014 · Dec 31, 2013 $385.47K
Sga Expense Q2 2014 · Jun 30, 2014 $334.63K
Sga Expense Q2 2014 · Jun 30, 2014 $682.79K
Sga Expense Q2 2014 · Jun 30, 2013 $370.92K
Sga Expense Q2 2014 · Jun 30, 2013 $810.6K
Net Income Q2 2014 · Jun 30, 2014 −$321K
Net Income Q2 2014 · Jun 30, 2014 −$653.01K
Net Income Q2 2014 · Jun 30, 2013 −$520.05K
Net Income Q2 2014 · Jun 30, 2013 −$817.91K
Operating Income Q2 2014 · Jun 30, 2014 −$317.12K
Operating Income Q2 2014 · Jun 30, 2014 −$647.77K
Operating Income Q2 2014 · Jun 30, 2013 −$352.49K
Operating Income Q2 2014 · Jun 30, 2013 −$368.71K
Revenue Q2 2014 · Jun 30, 2014 $18.43K
Revenue Q2 2014 · Jun 30, 2014 $36.86K
Revenue Q2 2014 · Jun 30, 2013 $18.43K
Revenue Q2 2014 · Jun 30, 2013 $36.86K